Education
About Us
Working with TipRanks
Follow Us
Johan Wedell-Wedellsborg Insider Profile
4 Followers
Johan Wedell-Wedellsborg, Director, Ten Percent Owner at Y-Mabs Therapeutics, holds 0.00 shares in Y-Mabs Therapeutics (Ticker: YMAB).
Johan Wedell-Wedellsborg Y-Mabs Therapeutics (YMAB)Director, Ten Percent Owner
Y-Mabs Therapeutics (YMAB)
Director, Ten Percent Owner
Ranked #5,752 out of 106,487 Corporate Insiders
Profitable Transactions
10 out of 15 Profitable Transactions
Average Return
+23.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Johan Wedell-Wedellsborg does not currently own shares as a corporate insider.
A breakdown of Johan Wedell-Wedellsborg's holdings
Insider Roles
Johan Wedell-Wedellsborg does not currently hold a role as a corporate insider.
Roles that Johan Wedell-Wedellsborg holds in companies
Most Profitable Insider Trade
Stock:
Y-Mabs Therapeutics
(YMAB)
(YMAB)
Rating:Informative Buy
Date:Nov 29, 2023 - Nov 29, 2024
Return:+99.60%
The most profitable trade made by Johan Wedell-Wedellsborg
Johan Wedell-Wedellsborg's Trading History
List of latest transactions for each holding click on a transaction to see Johan Wedell-Wedellsborg's performance on stock
You May Also Like
Johan Wedell-Wedellsborg insider profile FAQ
What is the percentage of profitable transactions made by Johan Wedell-Wedellsborg?
The percentage of profitable transactions made by Johan Wedell-Wedellsborg is 67%.
What is the average return per transaction made by Johan Wedell-Wedellsborg?
The average return per transaction made by Johan Wedell-Wedellsborg is 23.90%.
What stocks does Johan Wedell-Wedellsborg hold?
Johan Wedell-Wedellsborg holds: YMAB stocks.
What was Johan Wedell-Wedellsborg’s latest transaction?
Johan Wedell-Wedellsborg latest transaction was an Uninformative Sell of $39.26M.
What was Johan Wedell-Wedellsborg's most profitable transaction?
Johan Wedell-Wedellsborg’s most profitable transaction was an Informative Buy of YMAB stock on November 29, 2023. The return on the trade was 99.60%.
What is Johan Wedell-Wedellsborg's role in Y-Mabs Therapeutics?
Johan Wedell-Wedellsborg's role in Y-Mabs Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.